AC
KURA icon

AXQ Capital’s Kura Oncology KURA Stock Holding History

AXQ Capital’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-21,556
Closed -$175K – 1174
2026
Q1 		$175K Sell
21,556
-5,400
-20% -$46.4K 0.02% 779
2025
Q4 		$280K Buy
+26,956
New +$283K 0.06% 461
2025
Q3 		– Sell
-45,472
Closed -$262K – 716
2025
Q2 		$262K Buy
45,472
+19,369
+74% +$119K 0.08% 401
2025
Q1 		$172K Buy
+26,103
New +$203K 0.07% 410
2023
Q4 		– Sell
-12,943
Closed -$118K – 743
2023
Q3 		$118K Buy
+12,943
New +$131K 0.04% 419

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

AXQ Capital's KURA Position: Q2 2026 in Review

AXQ Capital sold out of Kura Oncology (KURA) in Q2 2026, closing a stake of 21,556 shares — an estimated $175K sold.

AXQ Capital first reported a position in KURA in Q3 2023 and held it in 5 quarters. The position peaked at $280K in Q4 2025. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • AXQ Capital reported no remaining Kura Oncology position as of Q2 2026 after selling out during the quarter.
  • AXQ Capital sold 21,556 Kura Oncology shares in Q2 2026, an estimated $175K.
  • AXQ Capital first reported a position in Kura Oncology in Q3 2023 and held it in 5 quarters.
  • AXQ Capital's Kura Oncology position peaked at $280K in Q4 2025.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.